Balancing Risk and Toxicity of Long-Term Multiple Myeloma Therapy |
10/02/2023 - 12:00pm to 1:00pm |
Cost, Communication, and Clinician Bias as Barriers to Patient-Centered Care |
10/30/2023 - 12:00pm to 1:00pm |
Evaluating Immunotherapy in NSCLC: Focus on Neoadjuvant Trials and Immune Related Adverse Events |
11/06/2023 - 12:00pm to 1:00pm |
Leveraging Digital Biomarkers in Geriatric Oncology |
11/13/2023 - 12:00pm to 1:00pm |
Novel Targets and Therapeutics in Prostate Cancer |
11/20/2023 - 12:00pm to 1:00pm |
Bench to Bed(side) - An Immunology Journey of Diversity Through Adversity |
11/27/2023 - 12:00pm to 1:00pm |
GI Oncology Program |
12/18/2023 - 12:00pm to 1:00pm |
Overcoming Microbiome-dependent Resistance to Cancer Immunotherapy |
01/22/2024 - 12:00pm to 1:00pm |
Gene Therapy for Sickle Cell Disease |
01/29/2024 - 12:00pm to 1:00pm |
Androgen Signaling Inhibitors: Special Considerations in Older Adults and Strategies to Reduce Toxicity |
02/12/2024 - 12:00pm to 1:00pm |